Beyond the registry
Safety and efficacy,
alongside the trial.
See what happened in trials with disclosed results, then trace each result back to its source.
The Gosset platform
Search connected pharma data, investigate the evidence and build research reports. One place to work through your next target, disease or asset.
The data behind the platform
Our knowledge graph connects drugs to their sponsors, trials, deals, indications, targets and modalities.
Beyond the registry
See what happened in trials with disclosed results, then trace each result back to its source.
Built for drug development
Proprietary ontologies organize diseases, targets and modalities into detailed classifications for precise retrieval.
Start with a target, disease or modality. Follow each asset into its clinical evidence, ownership and development history.

Built-in research workflows
Choose the work you need done, then describe your target, disease or asset. Each workflow uses its own research approach and output format.

See the output
Review the analysis, evidence and format in these existing Gosset examples.
See the analysis
A mechanism map from a public Gosset deep research report.
Open sample report
Full due-diligence assessment of a drug asset: thesis, evidence, competitive landscape, IP, pricing, and risks.
ExampleFrexalimab (anti-CD40L) for relapsing multiple sclerosis
View deckSide-by-side comparison of trial outcomes for a drug class or indication.
ExampleIL-13 vs IL-4Rα biologics in atopic dermatitis (EASI-75, IGA 0/1)
Open spreadsheetThe current standard of care for a given disease, grounded in drug labels and treatment guidelines.
ExampleGeneralized myasthenia gravis (FcRn & complement inhibitors)
Read reportBring Gosset’s data into ChatGPT or Claude when you want to research in a conversation.